BSECompany Update6d ago · 19 Sept 2026, 05:59 pm
Board of Director in the board meeting dated 19.09.2026 has approved the issuance and allotment of warrants convertible into shares to promoter subject to approval from shareholders.
Choksi Laboratories Ltd · 526546
✦ AI SummaryFundraise
Choksi Laboratories Ltd has approved the issuance and allotment of up to 3,50,000 convertible equity warrants to promoters, subject to shareholder approval.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact4/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Choksi Laboratories Ltd - 526546 - Announcement Under Regulation 30- Preferential Issue
Attachments (1)
📄pdf
Download →
3bce2eeb-68d7-43df-8ea0-a49283224a81.pdf
View document text
Corporate Office & Central Laboratory:
Survey No.9/1, Near Tulsiyana Industrial Park,
Gram Kumedi-453555 (MP) INDIA
Tel: +91 0731-3501112
Email: compliance_officer@choksilab.in
Website: www.choksilab.in
CIN: L85195MP1993PLC007471
19th September, 2026
The Department of Corporate Services
BSE Limited
Ground Floor, P. J. Tower,
Dalal Street, Mumbai - 400 001
Ref: Scrip Code: -526546, ISIN: INE493D01013
Dear Sir,
Sub: Outcome of meeting of Board of Directors held on September 19, 2026, pursuant to
Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015
Pursuant to Regulation 30 read with other applicable Regulation of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations 2015, we hereby inform you that the Board of
Directors of Choksi Laboratories Limited at their board meeting held on today i.e. Saturday,
September 19, 2026 at the Registered Office of the Company inter-alia, has, considered and
approved the following: -
1. Issuance and allotment of upto 3,50,000 (Three Lakh Fifty Thousand) warrants, fully
convertible into one fully paid-up equity share of the Company to the Persons belonging
to Promoter and Promoter Group, on preferential basis in terms of Chapter V of the
Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements)
Regulations, 2018 (the “ICDR Regulations”) as amended, Companies Act, 2013 and other
applicable laws, at price of Rs. 177/- (Rupees One Hundred Seventy-Seven Only) per
warrant (being the price not less than the minimum price determined with reference to
the Relevant Date i.e. September 17, 2026 in accordance with Regulation 165 of the
ICDR Regulations) aggregating upto maximum amount of Rs. 6,19,50,000 (Rupees Six
Crores Nineteen Lakhs Fifty Thousand Only).
The above preferential issue is subject to the approval of shareholders of the Company
at the ensuing Extra Ordinary General Meeting (“EGM”) and such regulatory/statutory
authorities as may be applicable.
The information in connection with the Preferential Issue pursuant to Regulation 30 of
the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with
SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, is
enclosed as Annexure-A.
ANY OTHER ITEM MAY BE TAKEN UP FOR CONSIDERATION WITH THE PERMISSION OF
THE CHAIRMAN AND WITH THE CONSENT OF A MAJORITY OF THE DIRECTORS
PRESENT IN THE MEETING
2. Approved Notice of Extra-Ordinary General Meeting, which shall be held on Saturday,
the 17th day of October, 2026 through Video Conferencing (“VC”) or Other Audio-Visual
Means (“OAVM”);
Corporate Office & Central Laboratory:
Survey No.9/1, Near Tulsiyana Industrial Park,
Gram Kumedi-453555 (MP) INDIA
Tel: +91 0731-3501112
Email: compliance_officer@choksilab.in
Website: www.choksilab.in
CIN: L85195MP1993PLC007471
3. Appointment of CS Surabhi Agrawal, Practicing Company Secretary as Scrutinizer for
conducting the e-voting process in the ensuing Extra Ordinary General Meeting of the
Company.
The Board Meeting commenced at 11.30 a.m. and concluded at 3:50 p.m.
Thanking you,
Yours faithfully,
For CHOKSI LABORATORIES LIMITED
PRAKHAR DUBEY
Company Secretary &
Compliance Officer
M. No.: A65011
Encl.: a/a
Corporate Office & Central Laboratory:
Survey No.9/1, Near Tulsiyana Industrial Park,
Gram Kumedi-453555 (MP) INDIA
Tel: +91 0731-3501112
Email: compliance_officer@choksilab.in
Website: www.choksilab.in
CIN: L85195MP1993PLC007471
ANNEXURE-A
Disclosure regarding the issue of Warrants on preferential basis as required under Regulation 30
and Schedule III of the Listing Regulations read with the Master Circular:
are as under:
SN Particulars Details
1 Types of Securities Convertible Equity Warrants
proposed to be issued
Each warrant shall carry a right to subscribe 1 (one) Equity
Share per warrant.
2 Types of Issuance Preferential allotment on a private placement basis in
accordance with the applicable provisions of the Companies
Act, 2013 and the rules made thereunder and SEBI (Issue of
Capital and Disclosure Requirements) Regulations, 2018, as
amended ("ICDR Regulations") and other applicable laws
3 Total number of securities Up to 3,50,000 (Three Lakh Fifty Thousand) Convertible
proposed to be issued or the Equity Warrants, each convertible into, or exchangeable for, 1
total amount for which the (one) fully paid-up equity share of the Company having face
securities will be issued value of Rs. 10/- (Rupees Ten Only) ("Equity Share(s)") each
(Approximately) at a price (including the Warrant Subscription Price and the
Warrant Exercise Price) of Rs. 177/- (Rupees One Hundred
and Fifty only) each payable in cash ("Warrant Issue Price"),
aggregating upto Rs. 6,19,50,000 (Rupees Six Crores Nineteen
Lakhs Fifty Thousand Only) ("Total Issue Size").
The price of the warrants has been determined in accordance
with the ICDR Regulations. The preferential issue will be
undertaken for cash consideration.
An amount equivalent to 25% of the Warrant Issue Price shall
be payable at the time of subscription and allotment of each
Warrant and the balance 75% shall be payable by the Warrant
holder(s) on the exercise of Warrant(s).
The price of the warrants and the number of Equity Shares to
be allotted on conversion of warrants shall be subject to
appropriate adjustments as permitted under applicable laws.
4 Name of the Proposed Sr. Name of the proposed Maximum Nos. of
Allottee’s(s) / Investors investor Warrants to be
Corporate Office & Central Laboratory:
Survey No.9/1, Near Tulsiyana Industrial Park,
Gram Kumedi-453555 (MP) INDIA
Tel: +91 0731-3501112
Email: compliance_officer@choksilab.in
Website: www.choksilab.in
CIN: L85195MP1993PLC007471
No. Allotted
1 Mr. Sunil Choksi 2,00,000
2 Ms. Himika Choksi 1,00,000
3 Mrs. Stela Choksi 50,000
5 Post allotment of securities- The convertible equity warrants are proposed to be allotted
outcome of the subscription to Persons belonging to Promoter and Promoter Group.
Details of the shareholding of Investors in the Company, prior
to and after the proposed Preferential Issue, are as under:
Name of Allottees Pre issue *Post issue
Shareholding shareholding
No. of % of No. of % of
shares shar Shares shar
ehol ehol
ding ding
Mr. Sunil Choksi 5,23,192 7.51 7,23,192 9.89
Ms. Himika Choksi 1,000 0.01 1,01,000 1.38
Mrs. Stela Choksi 2,20,000 3.16 2,70,200 3.69
*The post-issue shareholding pattern in the ab ove table has been prepared on the basis that the proposed allottee(s) will
subscribe to all the Warrants proposed to be issued to them and that the pre-issue shareholding pattern continues to remain
the same. The shareholding pattern has been calculated on a fully diluted basis, assuming conversion of all the Warrants into
Equity Shares. In the event that, for any reason, the proposed allottee’s do not or are unable to subscribe to and/or are not
allotted the Warrants, the shareholding pattern would undergo corresponding changes.
6 Issue Price Rs. 177/- (Rupees One Hundred Seventy Seven Only) per
convertible equity warrants as per ICDR Regulation
7 Number of Proposed 03 (Three)
Allottee’s(s)/ Investor
8 In case of convertibles — The tenure of the warrants shall not exceed 18 (eighteen)
intimation on conversion months from the date of allotment. Each warrant shall carry a
of securities or on lapse of right to subscribe 1 (one) Equity Share per warrant, which
the tenure of the may be exercised in one or more tranches during the period
instrument; commencing from the date of allotment of warrants until the
expiry of 18 (eighteen) months from the date of allotment of
the warrants.
In the event that, a warrant holder does not exercise the
Corporate Office & Central Laboratory:
Survey No.9/1, Near Tulsiyana Industrial Park,
Gram Kumedi-453555 (MP) INDIA
Tel: +91 0731-3501112
Email: compliance_officer@choksilab.in
Website: www.choksilab.in
CIN: L85195MP1993PLC007471
warrants within a period of 18 (Eighteen) months from the
date of allotment of such warrants,
[Showing first 8,000 characters — download PDF for full document]